Fortis Malar Hospitals Completes Postal Ballot with Overwhelming Shareholder Support

2 min read     Updated on 28 Mar 2026, 06:59 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Fortis Malar Hospitals successfully concluded its postal ballot process with overwhelming shareholder support exceeding 99.90% for all three board appointments. The company appointed Bidesh Chandra Paul as director and whole-time director, while re-appointing Shailaja Chandra as independent director for a second five-year term effective March 10, 2026.

powered bylight_fuzz_icon
36206680

*this image is generated using AI for illustrative purposes only.

Fortis Malar Hospitals Limited has successfully completed its postal ballot process with overwhelming shareholder approval for three key board appointments. The healthcare company received strong support across all resolutions, with approval rates exceeding 99.90% for each proposed appointment.

Postal Ballot Process Overview

The postal ballot concluded on March 27, 2026, with scrutinizer CS Mukesh Kumar Agarwal certifying the results. The company dispatched electronic notices on February 25, 2026, following the notice dated February 6, 2026, and published advertisements in Business Standard (English) and Rozana Spokesman (Punjabi) on February 26, 2026.

Process Details: Information
Record Date: February 20, 2026
Total Shareholders: 31,228
Participating Shareholders: 125
Voting Platform: KFin Technologies Limited
Scrutinizer: CS Mukesh Kumar Agarwal

Board Appointments Approved

All three resolutions received requisite majority approval with exceptional shareholder support:

Resolution 1: Director Appointment

Mr. Bidesh Chandra Paul (DIN: 08596135) was appointed as director with 1,17,60,663 votes in favor, representing 99.9067% approval.

Resolution 2: Whole-Time Director Appointment

Mr. Bidesh Chandra Paul's appointment as whole-time director was approved with 1,17,60,662 votes in favor, achieving 99.9067% approval rate.

Resolution 3: Independent Director Re-appointment

Ms. Shailaja Chandra (DIN: 03320688) was re-appointed as independent director for a second term of 5 consecutive years effective from March 10, 2026, with 1,17,60,763 votes in favor representing 99.9075% approval.

Detailed Voting Results

Resolution Votes in Favor Votes Against Approval %
Director Appointment: 1,17,60,663 10,983 99.9067%
Whole-Time Director: 1,17,60,662 10,984 99.9067%
Independent Director: 1,17,60,763 10,883 99.9075%

Shareholder Participation Analysis

The voting demonstrated strong promoter group support with complete participation, while public participation remained limited. Out of 1,87,41,759 total shares, 1,17,71,646 shares participated in voting, representing 62.81% of outstanding shares.

Shareholder Category Total Shares Votes Polled Participation %
Promoter Group: 1,17,52,402 1,17,52,402 100.00%
Public Institutions: 18,023 0 0.00%
Public Non-Institutions: 69,71,334 19,244 0.276%

Regulatory Compliance

The postal ballot was conducted in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and various MCA circulars. The company provided electronic voting facility only, with no physical postal ballot forms received. Two shareholders holding 15 equity shares abstained from voting across all resolutions.

Company Secretary Vinti Verma confirmed that all resolutions were deemed passed on March 27, 2026, strengthening the company's board composition and governance framework for future operations.

Historical Stock Returns for Fortis Malar Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
+10.79%-3.97%-14.56%-28.80%-43.09%-15.33%

What strategic initiatives might Mr. Bidesh Chandra Paul implement as the new whole-time director to drive Fortis Malar's growth in the competitive healthcare sector?

How could the strengthened board composition impact Fortis Malar's expansion plans or potential mergers and acquisitions in the healthcare industry?

Will the low public shareholder participation rate (0.276%) prompt the company to enhance investor engagement strategies in future corporate decisions?

like17
dislike

Fortis Malar Hospitals Receives Income Tax Demand of ₹48.22 Lakh for Assessment Year 2018-19

1 min read     Updated on 25 Mar 2026, 07:27 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Fortis Malar Hospitals Limited received an Income Tax rectification order for assessment year 2018-19 with an additional demand of ₹48,22,435, pertaining to interest under section 234D. The company received the order on March 24, 2026, and disclosed it under SEBI regulations. Management considers the demand not maintainable and plans to file an appeal, expecting no material impact on financials or operations.

powered bylight_fuzz_icon
35992621

*this image is generated using AI for illustrative purposes only.

Fortis Malar Hospitals Limited has received an Income Tax rectification order with an additional demand of ₹48,22,435 for assessment year 2018-19. The company disclosed this development to the stock exchanges under SEBI listing regulations on March 25, 2026.

Tax Order Details

The Income Tax rectification order was dated March 19, 2026, and pertains to assessment year 2018-19. The company received the order on March 24, 2026, at 2:51 PM, as communicated in its regulatory filing.

Parameter Details
Authority Income Tax Authority
Order Date March 19, 2026
Assessment Year 2018-19
Additional Demand ₹48,22,435
Nature of Demand Interest under Section 234D
Receipt Date March 24, 2026 at 2:51 PM

Company's Response and Impact Assessment

Fortis Malar Hospitals has stated that based on its assessment, the demand is not maintainable. The company is working on filing an appeal against the Income Tax order. Management has indicated that it does not envisage any material impact on the company's financials, operations, or other activities due to this demand.

Regulatory Compliance

The disclosure was made in continuation of an earlier intimation dated April 1, 2025, and pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015. The company provided details as per SEBI Master Circular number HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The filing was signed by Vinti Verma, Company Secretary and Compliance Officer, with membership number A44528, and submitted digitally on March 25, 2026.

Historical Stock Returns for Fortis Malar Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
+10.79%-3.97%-14.56%-28.80%-43.09%-15.33%

What is the likelihood of success for Fortis Malar's appeal, and how long could the legal process take to resolve?

Could this tax rectification signal potential scrutiny of other assessment years or subsidiaries within the Fortis healthcare network?

How might investor confidence be affected if similar tax demands emerge for other major healthcare companies in India?

like19
dislike

More News on Fortis Malar Hospitals

1 Year Returns:-43.09%